Last reviewed · How we verify
NCT07416292: ListenFuture
ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents
trial in Hearing Disorders and Deafness in 256 participants. Currently enrolling.
31 December 2029
Quick facts
| Lead sponsor | Heikki Löppönen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 256 |
| Start date | 1 March 2026 |
| Primary completion | 31 December 2029 |
| Estimated completion | 31 December 2031 |
| Sites | 7 locations across Finland |
Conditions studied
- Hearing Disorders and Deafness — all drugs for Hearing Disorders and Deafness →
Sponsor
Heikki Löppönen
Who can join
Adults 11 to 16, any sex, with Hearing Disorders and Deafness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
ListenFuture, a nation-wide multidisciplinary project, brings new knowledge on complex associations between listening, cognition, language, literacy, and psychosocial wellbeing in deaf and hard-of-hearing (DHH) adolescents. Earlier findings indicate that DHH adolescents remain at a risk to achieving age-appropriate skills. The associations among these skills can also be language-dependent. The investigators use behavioral methods and questionnaires. The investigators study speech perception in noise, listening, and listening-related fatigue to reveal how DHH adolescents cope in today's noisy environment. The investigators study cognitive skills and executive functions, spoken language and literacy skills to find out the current state-of-knowledge. The investigators study psychosocial wellbeing, school burnout and factors associated with them. The investigators will utilize supervised and interpretable machine learning to analyse the performance domains that could best predict the outcomes of DHH adolescents. The investigators expect our project to have broad societal impact for DHH adolescents, healthcare, school, and other stakeholders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07416292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07416292 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heikki Löppönen
- Last refreshed: 25 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07416292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing